STE logo

STERIS plc (Ireland) (STE)

$257.41

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on STE

Market cap

$25.00B

EPS

8.43

P/E ratio

26.2

Price to sales

3.46

Dividend yield

1.072%

Beta

0.865011

Price on STE

Previous close

$261.91

Today's open

$259.32

Day's range

$256.88 - $262.50

52 week range

$195.14 - $269.44

Profile about STE

CEO

Daniel A. Carestio

Employees

17937

Headquarters

Dublin 2,

Exchange

New York Stock Exchange

Shares outstanding

97107020

Issue type

Common Stock

STE industries and sectors

Healthcare

Medical Equipment & Supplies

News on STE

Dividend Champion, Contender, And Challenger Highlights: Week Of November 15

A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates.

news source

Seeking Alpha • Nov 13, 2026

news preview

What STERIS (STE) Said on Its Q2 Earnings Call

STERIS NYSE: STE raised its fiscal 2027 earnings outlook after reporting higher second-quarter revenue and profit, as tariff refunds helped expand margins and strong Life Sciences equipment shipments offset a slower start to the year in its sterilization business.

news source

MarketBeat • Nov 7, 2026

news preview

STERIS plc (STE) Q2 2027 Earnings Call Transcript

STERIS plc ( STE ) Q2 2027 Earnings Call November 5, 2026 9:00 AM EST Company Participants Julie Winter - Vice President of Investor Relations & Corporate Communications Karen Burton - Senior VP, CFO & Chief Accounting Officer Daniel Carestio - President, CEO & Director Conference Call Participants Brett Fishbin - KeyBanc Capital Markets Inc., Research Division Patrick Andrew Wood - UBS Investment Bank, Research Division Steven Etoch - Stephens Inc., Research Division Michael Polark - Wolfe Research, LLC Michael Matson - Needham & Company, LLC, Research Division Jason Bednar - Piper Sandler & Co., Research Division Presentation Operator Good day, and welcome to the STERIS plc Second Quarter 2027 Financial Results Conference Call. [Operator Instructions] Please note this event is being recorded.

news source

Seeking Alpha • Nov 5, 2026

news preview

STE Stock Up on Q2 Earnings & Revenue Beat, '27 EPS View Up

STERIS beats Q2 fiscal 2027 earnings and revenue estimates, fueled by strong segment growth and margin gains, and raises its full-year adjusted EPS outlook.

news source

Zacks Investment Research • Nov 5, 2026

news preview

STERIS Announces Financial Results for Fiscal 2027 Second Quarter

DUBLIN, IRELAND, Nov. 04, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2027 second quarter ended September 30, 2026. Total revenue for the second quarter of fiscal 2027 increased 9% to $1.6 billion compared with $1.5 billion in the second quarter of fiscal 2026. Constant currency organic revenue growth was 8% in the second quarter.

news source

GlobeNewsWire • Nov 4, 2026

news preview

Steris (STE) Q2 Earnings and Revenues Surpass Estimates

Steris (STE) came out with quarterly earnings of $2.94 per share, beating the Zacks Consensus Estimate of $2.67 per share. This compares to earnings of $2.47 per share a year ago.

news source

Zacks Investment Research • Nov 4, 2026

news preview

Compared to Estimates, Steris (STE) Q2 Earnings: A Look at Key Metrics

Although the revenue and EPS for Steris (STE) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

news source

Zacks Investment Research • Nov 5, 2026

news preview

STERIS Set to Report Q2 Earnings: What's in the Cards for the Stock?

STE's second-quarter fiscal 2027 earnings may benefit from Healthcare growth, recent acquisitions, easing AST comparisons and continued margin expansion.

news source

Zacks Investment Research • Oct 30, 2026

news preview

2 Healthcare Technology Stocks for a Digital Health Boom

GMED and STE offer exposure to healthcare technology growth, with projected 2026 EPS gains, attractive valuations and innovations in essential medical services.

news source

Zacks Investment Research • Oct 29, 2026

news preview

STERIS Announces Dividend of $0.69 per share

DUBLIN, IRELAND, Oct. 28, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly dividend of $0.69 per share. The dividend is payable on December 17, 2026, to shareholders of record at the close of business on November 17, 2026.

news source

GlobeNewsWire • Oct 28, 2026

news preview

¹ Disclosures

Get started with M1

Invest in STERIS plc (Ireland)

Open an M1 investment account to buy and sell STERIS plc (Ireland) commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in STE on M1